ACB
Aurora Cannabis Inc
NASDAQ: ACB · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$5.24
+0.96% today
Updated 2026-11-06
Market cap
$257.04M
P/E ratio
—
P/S ratio
0.82x
EPS (TTM)
$-0.61
Dividend yield
—
52W range
$3 – $6
Volume
1.3M
Aurora Cannabis Inc (ACB) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$5.24
12-Month target
—
2030 Target
—
Intrinsic (DCF)
—
Financial forecast
| Metric | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
| Revenue | $0.2B | $0.2B | $0.3B | $0.3B | $0.3B |
| EPS | — | — | — | — | — |
CAGR applied: — (capped 20%) · P/E: 25.00x (capped 25x) · Margin: -38.30%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.